SBFM Stock Catalyst: Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments

Aug 7, 2026 · 9:00am ET

The company has initiated shipments to pharmacies following the launch.

Max move

+33.6%

High of day $1.87

Sparker timei

9:00am ET

SBFM · Aug 7, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Sunshine Biopharma Inc. (Nasdaq: SBFM) announced the launch of its Amoxicillin product in Canada and the commencement of shipments to pharmacies. The move is part of the company's strategy to expand its pharmaceutical offerings in the Canadian market.

The Canadian antibiotics market is valued at $4.9 billion. Sunshine Biopharma's free float stands at 498,192 shares.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time SBFM sparks.

Download Sniper App →

Catch the next SBFM-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →